Publication: 4482

Publication: 4482

Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results.

PubMed

DOI

Google Scholar

Citation:: J Clin Oncol vol 43 (32) 3526-35

Year:: 2025
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: 3981
Children:: None

Program:: OGC
Primary Committee:: Leukemia
Sec. Committees:

Pharmas:: Pfizer; Amgen
Grants:: U10CA180821, U10CA180882, UG1CA189819, UG1CA189824, UG1CA232760, UG1CA233180, UG1CA233234, UG1CA233253, UG1CA233320, UG1CA233327, UG1CA233331, UG1CA233339, UG1CA233373, UG1CA239767 U10CA180820 (EA)

Corr. Author:
Authors:: Matthew J Wieduwilt Jun Yin Oudom Kour Rebecca Teske Wendy Stock Carolin Escherich Jun Yang Zhenhua Li Kenneth Byrd Kimberley Doucette James Mangan Scott Hall Alice S Mims Katarzyna Jamieson Shira N Dinner Ali W Bseiso Giorgia Giordano Caner Saygin Geoffrey L Uy Mark R Litzow Richard M Stone

Networks:: CA249, CAPITAL, CHRISTIANA, KANSAS, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-OH007, NC002, WINCORP

Study: Alliance-A041703
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: